PTC Therapeutics
PTCT
#2901
Rank
HK$44.51 B
Marketcap
HK$537.82
Share price
-3.05%
Change (1 day)
61.36%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : HK$24.30 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are HK$24.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$24.15 B10.98%
2024-12-31HK$21.76 B2.66%
2023-12-31HK$21.19 B32.17%
2022-12-31HK$16.03 B6.21%
2021-12-31HK$15.10 B12.84%
2020-12-31HK$13.38 B66.92%
2019-12-31HK$8.01 B33.22%
2018-12-31HK$6.01 B227.47%
2017-12-31HK$1.83 B58.24%
2016-12-31HK$1.16 B7.58%
2015-12-31HK$1.07 B300.49%
2014-12-31HK$0.26 B126.3%
2013-12-31HK$0.11 B-52.37%
2012-12-31HK$0.25 B-88.61%
2011-12-31HK$2.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
HK$504.23 B 1,974.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
HK$54.62 B 124.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$1.87 B-92.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$17.29 B-28.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
HK$0.85 B-96.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
HK$2.10 B-91.32%๐Ÿ‡บ๐Ÿ‡ธ USA